Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions (Q40101106)

17 September 2017

title

Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions (English)

1 reference

17 September 2017

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Haijun Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Roxanne R Mody

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Eric Luna

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Donna Armylagos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Mary R Schwartz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Dina R Mody

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Yimin Ge

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

15 January 2016

1 reference

17 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

317-323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

The promise of global cervical-cancer prevention

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Primary high-risk HPV screening for cervical cancer in post-menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

The HPV test has similar sensitivity but more overdiagnosis than the Pap test--a randomised health services study on cervical cancer screening in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

The ATHENA human papillomavirus study: design, methods, and baseline results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Unexpected high prevalence of HPV 90 infection in an underserved population: is it really a low-risk genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Associations of high-risk HPV types and viral load with cervical cancer in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Sensitivity and specificity of HPV testing: what are the facts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21687

21 January 2018

Identifiers

DOI

10.1002/CNCY.21687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26774025%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference